Amedeo Smart

Free Medical Literature Service


 

Amedeo

Ovarian Neoplasms

  Free Subscription

Articles published in
Oncogene
    July 2022
  1. SHEN Z, Gu L, Liu Y, Wang L, et al
    PLAA suppresses ovarian cancer metastasis via METTL3-mediated m(6)A modification of TRPC3 mRNA.
    Oncogene. 2022 Jul 22. pii: 10.1038/s41388-022-02411.
    >> Share

    June 2022
  2. MOTOHARA T, Masuda K, Morotti M, Zheng Y, et al
    Correction to: An evolving story of the metastatic voyage of ovarian cancer cells: cellular and molecular orchestration of the adipose-rich metastatic microenvironment.
    Oncogene. 2022 Jun 6. pii: 10.1038/s41388-022-02356.
    >> Share

    April 2022
  3. ZHU S, Zhang C, Cao D, Bai J, et al
    Genomic and TCR profiling data reveal the distinct molecular traits in epithelial ovarian cancer histotypes.
    Oncogene. 2022 Apr 25. pii: 10.1038/s41388-022-02277.
    >> Share

    February 2022
  4. KWON J, Choi H, Ware AD, Morillo BC, et al
    USP13 promotes development and metastasis of high-grade serous ovarian carcinoma in a novel mouse model.
    Oncogene. 2022 Feb 16. pii: 10.1038/s41388-022-02224.
    >> Share

  5. LIN L, Shi K, Zhou S, Cai MC, et al
    SOX17 and PAX8 constitute an actionable lineage-survival transcriptional complex in ovarian cancer.
    Oncogene. 2022 Feb 5. pii: 10.1038/s41388-022-02210.
    >> Share

    January 2022
  6. LI J, Zheng C, Wang M, Umano AD, et al
    ROS-regulated phosphorylation of ITPKB by CAMK2G drives cisplatin resistance in ovarian cancer.
    Oncogene. 2022 Jan 18. pii: 10.1038/s41388-021-02149.
    >> Share

  7. JAMES NE, Woodman M, Ribeiro JR
    Prognostic immunologic signatures in epithelial ovarian cancer.
    Oncogene. 2022 Jan 14. pii: 10.1038/s41388-022-02181.
    >> Share

  8. KAN T, Zhang S, Zhou S, Zhang Y, et al
    Single-cell RNA-seq recognized the initiator of epithelial ovarian cancer recurrence.
    Oncogene. 2022 Jan 7. pii: 10.1038/s41388-021-02139.
    >> Share

    November 2021
  9. YIN L, Zeng Y, Zeng R, Chen Y, et al
    Protein kinase RNA-activated controls mitotic progression and determines paclitaxel chemosensitivity through B-cell lymphoma 2 in ovarian cancer.
    Oncogene. 2021 Nov 19. pii: 10.1038/s41388-021-02117.
    >> Share

  10. BOUDHRAA Z, Zaoui K, Fleury H, Cahuzac M, et al
    NR1D1 regulation by Ran GTPase via miR4472 identifies an essential vulnerability linked to aneuploidy in ovarian cancer.
    Oncogene. 2021 Nov 6. pii: 10.1038/s41388-021-02082.
    >> Share

    September 2021
  11. MOSKOVICH D, Finkelshtein Y, Alfandari A, Rosemarin A, et al
    Targeting the DIO3 enzyme using first-in-class inhibitors effectively suppresses tumor growth: a new paradigm in ovarian cancer treatment.
    Oncogene. 2021 Sep 23. pii: 10.1038/s41388-021-02020.
    >> Share

    August 2021
  12. LI H, Qi Z, Niu Y, Yang Y, et al
    FBP1 regulates proliferation, metastasis, and chemoresistance by participating in C-MYC/STAT3 signaling axis in ovarian cancer.
    Oncogene. 2021 Aug 6. pii: 10.1038/s41388-021-01957.
    >> Share

    July 2021
  13. LI Y, Fei H, Lin Q, Liang F, et al
    ZEB2 facilitates peritoneal metastasis by regulating the invasiveness and tumorigenesis of cancer stem-like cells in high-grade serous ovarian cancers.
    Oncogene. 2021 Jul 1. pii: 10.1038/s41388-021-01913.
    >> Share

    June 2021
  14. ZHANG J, Guan W, Xu X, Wang F, et al
    A novel homeostatic loop of sorcin drives paclitaxel-resistance and malignant progression via Smad4/ZEB1/miR-142-5p in human ovarian cancer.
    Oncogene. 2021 Jun 23. pii: 10.1038/s41388-021-01891.
    >> Share

  15. WU Y, Guo Q, Ju X, Hu Z, et al
    HNRNPH1-stabilized LINC00662 promotes ovarian cancer progression by activating the GRP78/p38 pathway.
    Oncogene. 2021 Jun 19. pii: 10.1038/s41388-021-01884.
    >> Share

  16. WU YH, Huang YF, Chang TH, Chen CC, et al
    COL11A1 activates cancer-associated fibroblasts by modulating TGF-beta3 through the NF-kappaB/IGFBP2 axis in ovarian cancer cells.
    Oncogene. 2021 Jun 11. pii: 10.1038/s41388-021-01865.
    >> Share

    May 2021
  17. TAN J, Zheng X, Li M, Ye F, et al
    C/EBPbeta promotes poly(ADP-ribose) polymerase inhibitor resistance by enhancing homologous recombination repair in high-grade serous ovarian cancer.
    Oncogene. 2021 May 8. pii: 10.1038/s41388-021-01788.
    >> Share

    April 2021
  18. LINDZEN M, Ghosh S, Noronha A, Drago D, et al
    Targeting autocrine amphiregulin robustly and reproducibly inhibits ovarian cancer in a syngeneic model: roles for wildtype p53.
    Oncogene. 2021 Apr 30. pii: 10.1038/s41388-021-01784.
    >> Share

    January 2021
  19. YOSHIDA K, Yokoi A, Sugiyama M, Oda S, et al
    Expression of the chrXq27.3 miRNA cluster in recurrent ovarian clear cell carcinoma and its impact on cisplatin resistance.
    Oncogene. 2021 Jan 8. pii: 10.1038/s41388-020-01595.
    >> Share

  20. NOH K, Bach DH, Choi HJ, Kim MS, et al
    The hidden role of paxillin: localization to nucleus promotes tumor angiogenesis.
    Oncogene. 2021;40:384-395.
    >> Share

    October 2020
  21. ZHANG Q, Zhou W, Yu S, Ju Y, et al
    Metabolic reprogramming of ovarian cancer involves ACSL1-mediated metastasis stimulation through upregulated protein myristoylation.
    Oncogene. 2020 Oct 20. pii: 10.1038/s41388-020-01516.
    >> Share

  22. RANZUGLIA V, Lorenzon I, Pellarin I, Sonego M, et al
    Serum- and glucocorticoid- inducible kinase 2, SGK2, is a novel autophagy regulator and modulates platinum drugs response in cancer cells.
    Oncogene. 2020;39:6370-6386.
    >> Share

    September 2020
  23. XU Z, Li X, Li H, Nie C, et al
    Suppression of DDX39B sensitizes ovarian cancer cells to DNA-damaging chemotherapeutic agents via destabilizing BRCA1 mRNA.
    Oncogene. 2020 Sep 28. pii: 10.1038/s41388-020-01482.
    >> Share

  24. MEHNER C, Miller E, Hockla A, Coban M, et al
    Targeting an autocrine IL-6-SPINK1 signaling axis to suppress metastatic spread in ovarian clear cell carcinoma.
    Oncogene. 2020 Sep 14. pii: 10.1038/s41388-020-01451.
    >> Share

    July 2020
  25. NAIR J, Huang TT, Murai J, Haynes B, et al
    Resistance to the CHK1 inhibitor prexasertib involves functionally distinct CHK1 activities in BRCA wild-type ovarian cancer.
    Oncogene. 2020 Jul 9. pii: 10.1038/s41388-020-1383.
    >> Share

    May 2020
  26. LI J, Alvero AB, Nuti S, Tedja R, et al
    CBX7 binds the E-box to inhibit TWIST-1 function and inhibit tumorigenicity and metastatic potential.
    Oncogene. 2020;39:3965-3979.
    >> Share

    April 2020
  27. PELLARIN I, Dall'Acqua A, Gambelli A, Pellizzari I, et al
    Splicing factor proline- and glutamine-rich (SFPQ) protein regulates platinum response in ovarian cancer-modulating SRSF2 activity.
    Oncogene. 2020 Apr 24. pii: 10.1038/s41388-020-1292.
    >> Share

  28. KAN T, Wang W, Ip PP, Zhou S, et al
    Single-cell EMT-related transcriptional analysis revealed intra-cluster heterogeneity of tumor cell clusters in epithelial ovarian cancer ascites.
    Oncogene. 2020 Apr 13. pii: 10.1038/s41388-020-1288.
    >> Share

    March 2020
  29. CHOI PW, So WW, Yang J, Liu S, et al
    MicroRNA-200 family governs ovarian inclusion cyst formation and mode of ovarian cancer spread.
    Oncogene. 2020 Mar 25. pii: 10.1038/s41388-020-1264.
    >> Share

  30. TAMURA R, Yoshihara K, Nakaoka H, Yachida N, et al
    XCL1 expression correlates with CD8-positive T cells infiltration and PD-L1 expression in squamous cell carcinoma arising from mature cystic teratoma of the ovary.
    Oncogene. 2020 Mar 2. pii: 10.1038/s41388-020-1237.
    >> Share

  31. HAYASHI T, Sano K, Aburatani H, Yaegashi N, et al
    Initialization of epithelial cells by tumor cells in a metastatic microenvironment.
    Oncogene. 2020;39:2638-2640.
    >> Share

    February 2020
  32. CHEN C, Gupta P, Parashar D, Nair GG, et al
    ERBB3-induced furin promotes the progression and metastasis of ovarian cancer via the IGF1R/STAT3 signaling axis.
    Oncogene. 2020 Feb 6. pii: 10.1038/s41388-020-1194.
    >> Share

    January 2020
  33. KWEON J, Jang AH, Shin HR, See JE, et al
    A CRISPR-based base-editing screen for the functional assessment of BRCA1 variants.
    Oncogene. 2020;39:30-35.
    >> Share

    November 2019
  34. CLUZET V, Devillers MM, Petit F, Chauvin S, et al
    Aberrant granulosa cell-fate related to inactivated p53/Rb signaling contributes to granulosa cell tumors and to FOXL2 downregulation in the mouse ovary.
    Oncogene. 2019 Nov 19. pii: 10.1038/s41388-019-1109.
    >> Share

  35. KIM YS, Gupta Vallur P, Jones VM, Worley BL, et al
    Context-dependent activation of SIRT3 is necessary for anchorage-independent survival and metastasis of ovarian cancer cells.
    Oncogene. 2019 Nov 13. pii: 10.1038/s41388-019-1097.
    >> Share

  36. SUN C, Li X, Guo E, Li N, et al
    MCP-1/CCR-2 axis in adipocytes and cancer cell respectively facilitates ovarian cancer peritoneal metastasis.
    Oncogene. 2019 Nov 8. pii: 10.1038/s41388-019-1090.
    >> Share

  37. ASARE-WEREHENE M, Nakka K, Reunov A, Chiu CT, et al
    The exosome-mediated autocrine and paracrine actions of plasma gelsolin in ovarian cancer chemoresistance.
    Oncogene. 2019 Nov 7. pii: 10.1038/s41388-019-1087.
    >> Share

    September 2019
  38. TUNG CH, Kuo LW, Huang MF, Wu YY, et al
    MicroRNA-150-5p promotes cell motility by inhibiting c-Myb-mediated Slug suppression and is a prognostic biomarker for recurrent ovarian cancer.
    Oncogene. 2019 Sep 30. pii: 10.1038/s41388-019-1025.
    >> Share

    July 2019
  39. KLEINSCHMIDT EG, Miller NLG, Ozmadenci D, Tancioni I, et al
    Rgnef promotes ovarian tumor progression and confers protection from oxidative stress.
    Oncogene. 2019 Jul 15. pii: 10.1038/s41388-019-0881.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016